Does continuous ST-segment monitoring add prognostic information to the TIMI, PURSUIT, and GRACE risk scores?

Annals of Noninvasive Electrocardiology

Volumn 16, Issue 3, 2011, Pages 239-249

  Carmo, Pedro ^a   Ferreira, Jorge ^a   Aguiar, Carlos ^a   Ferreira, Antõnio ^a   Raposo, Luís ^a   Gonçalves, Pedro ^a   Brito, João ^a   Silva, Aniceto ^a  

^a HOSPITAL DE SANTA CRUZ   (Portugal)

Author keywords

acute coronary syndromes prognosis; risk scores; ST segment monitoring

Indexed keywords

CREATININE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST;

ACCURACY; ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DEATH; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HAZARD RATIO; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT; STATISTICAL ANALYSIS; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; RISK ASSESSMENT; ROC CURVE; STATISTICS, NONPARAMETRIC;

EID: 79960610675     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2011.00438.x     Document Type: Article

References (36)

1. Anderson JL, Adams CD, Antman AM, et al,. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the 2002 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction): Developed in collaboration with the American College of Emergency Physicians, American College of Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50: e1-e157.
2. Hamm C, Ardissino D, Boersma E, et al,. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 2007; 28: 1598-1660. (Pubitemid 47227122)
3. Granger CB, Goldberg RJ, Dabbous OH, et al,. For the Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345-2353. (Pubitemid 37310196)
4. Antman EM, Cohen M, Bernink PJLM, et al,. The TIMI risk score for unstable angina/non-ST elevation MI. J Am Med Assoc 2000; 284: 835-842.
5. Boersma E, Pieper KS, Steyerberg EW, et al,. For the PURSUIT Investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation 2000; 101: 2557-2567. (Pubitemid 30350632)
6. de Araujo Goncalves P, Ferreira J, et al,. TIMI, PURSUIT, and GRACE risk scores: Sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005; 26: 865-872. (Pubitemid 40676566)
7. Wong CK, White HD,. Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes. Eur Heart J 2005; 26: 851- 852. (Pubitemid 40676560)
8. Yan AT, Yan RT, Tan M, et al,. In-hospital revascularization and one year outcome of acute coronary syndrome patients stratified by the GRACE risk score. Am J Cardiol 2005; 96: 913-916. (Pubitemid 41362512)
9. Gottlieb SO, Weisfeldt ML, Ouyang P, et al,. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986; 314: 1214-1219. (Pubitemid 16106407)
10. Langer A, Freeman MR, Armstrong PW,. ST segment shift in unstable angina: Pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989; 13: 1495-1502. (Pubitemid 19145547)
11. Langer A, Minkowitz J, Dorian P, et al,. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. J Am Coll Cardiol 1992; 20: 1313-1317.
12. Andersen K, Eriksson P, Dellborg M,. Non-invasive risk stratification within 48 h of hospital admission in patients with unstable coronary disease. Eur Heart J 1997; 18: 780-788. (Pubitemid 27208150)
13. Holmvang L, Andersen K, Dellborg M, et al,. Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease. Am J Cardiol 1999; 83: 667-674. (Pubitemid 29115434)
14. Norgaard BL, Andersen K, Dellborg M, et al,. Admission risk assessment by cardiac troponin T in unstable coronary artery disease: Additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia. J Am Coll Cardiol 1999; 33: 1519-1527.
15. Jernberg T, Lindahl B, Wallentin L,. The combination of a continuous 12-lead ECG and troponin T: A valuable tool for risk stratification during the first 6 hours in patients with chest pain and a nondiagnostic ECG. Eur Heart J 2000; 21: 1464-1472. (Pubitemid 30636326)
16. Yan A, Yan R, Tan M, et al,. Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndrome. INTERACT Investigators. Am Heart J 2007; 153: 500-506. (Pubitemid 46454252)
17. Aguiar C, Ferreira J, Seabra-Gomes R,. Prognostic value of continuous ST segment monitoring in patients with non-ST-segment elevation acute coronary syndromes. Ann Noninvasive Electrocardiol 2002; 7: 29-39. (Pubitemid 34171500)
18. Drew BJ, Krucoff MW,. Multilead ST-segment monitoring in patients with acute coronary syndromes: A consensus statement for healthcare professionals. ST Segment Monitoring Practice Guideline International Working Group. Am J Crit Care 1999; 6: 372-386.
19. Morrow DA, Antman EM, Snapinn SM, et al,. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI risk score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 2002; 23: 223-229. (Pubitemid 36358244)
20. Thygesen K, Alpert JS, White HD,. On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525-2538.
21. Cohn PF, Fox KM, Daly C,. Silent myocardial ischemia. Circulation 2003; 108: 1263-1277. (Pubitemid 37099998)
22. Krucoff MW, Johanson P, Baeza R, et al,. Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: Assessing the dynamics of epicardial and myocardial reperfusion. Circulation 2004; 110: e533-e539.
23. Akkerhuis KM, Klootwijk PA, Lindeboom W, et al,. Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events: Meta-analysis of three studies involving 995 patients. Eur Heart J 2001; 22: 1997-2006. (Pubitemid 33089542)
24. Patel DJ, Holdright DR, Knight CJ, et al,. Early continuous ST-segment monitoring in unstable angina: Prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 1996; 75: 222-228. (Pubitemid 26094959)
25. Langer A, Singh N, Freeman MR, et al,. Detection of silent ischemia adds to the prognostic value of coronary anatomy and left ventricular function in predicting outcome in patients with unstable angina. Can J Cardiol 1995; 11: 117-122.
26. Jernberg T, Lindahl B, Wallentin L,. ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction. J Am Coll Cardiol 1999; 34: 1413-1419. (Pubitemid 29528651)
27. Shaun GG, Barr A, Sobtchouk A, et al,. Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: The Canadian ESSENCE ST Segment Monitoring Substudy. J Am Coll Cardiol 2000; 36: 1507-1513.
28. Romeo F, Rosano GM, Martuscelli E, et al,. Unstable angina: Role of silent ischemia and total ischemic time (silent plus painful ischemia), a 6-year follow-up. J Am Coll Cardiol 1992; 19: 1173-1179.
29. Pozzati A, Bugiardini R, Borghi A, et al,. Transient ischaemia refractory to conventional medical treatment in unstable angina: Angiographic correlates and prognostic implications. Eur Heart J 1992; 13: 360-365.
30. Steg PG, Dabbous OH, Feldman LJ, et al,. For the Global Registry of Acute Coronary Events Investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: Observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004; 109: 440-442.
31. Santopinto JJ, Fox KA, Goldberg RJ, et al,. for the Global Registry of Acute Coronary Events Investigators. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: Findings from Global Registry of Acute Coronary Events (GRACE). Heart 2003; 89 1003-1008. (Pubitemid 37046830)
32. Goodman SG, Fitchett D, Armstrong PW, et al,. Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Circulation 2003; 107: 238-244. (Pubitemid 36135218)
33. Mandelzweig L, Battler A, Boyko V, et al,. Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006; 27: 2285-2293. (Pubitemid 44453571)
34. Akkerhuis KM, Maas AC, Klootwijk PA, et al,. Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: Relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy. J Electrocardiol 2000; 33: 127-136. (Pubitemid 30257784)
35. Patel DJ, Knight CJ, Holdright DR, et al,. Pathophysiology of transient myocardial ischemia in acute coronary syndromes. Characterization by continuous ST-segment monitoring. Circulation 1997; 95: 1185-1192. (Pubitemid 27097829)
36. Klootwijk P, Meij S, von Es GA, et al,. Comparison of usefulness of computer assisted continuous 48-h 3-lead with 12-lead ECG ischaemia monitoring for detection and quantitation of ischaemia in patients with unstable angina. Eur Heart J 1997; 18: 931-940. (Pubitemid 27230665)